
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $879.2M | $684M | $800.6M | $1.1B | $1.3B | |
Revenue Growth (YoY) | -13.71% | -22.2% | 17.05% | 41.49% | 18.92% | |
Cost of Revenues | $783M | $611.9M | $764.1M | $993.9M | $1.1B | |
Gross Profit | $96.2M | $72.1M | $36.5M | $138.9M | $256.2M | |
Gross Profit Margin | 10.94% | 10.55% | 4.57% | 12.26% | 19.02% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $74.2M | $65.6M | $77.2M | $87.2M | $116.8M | |
Other Inc / (Exp) | $738K | $1.2M | $2.3M | -$8.8M | -$6M | |
Operating Expenses | $74.2M | $65.6M | $77.2M | $87.2M | $116.8M | |
Operating Income | $22M | $6.5M | -$40.7M | $51.7M | $139.3M | |
Net Interest Expenses | $12.2M | $9.7M | $14.7M | $17M | $6.4M | |
EBT. Incl. Unusual Items | $10.5M | -$2M | -$53.1M | $25.8M | $126.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.5M | -$1.2M | -$11.5M | $9M | $33.2M | |
Net Income to Company | $12.2M | -$289K | -$45.8M | $23.8M | $105.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $12.2M | -$289K | -$45.8M | $23.8M | $105.5M | |
Basic EPS (Cont. Ops) | $0.45 | -$0.01 | -$1.48 | $0.74 | $3.27 | |
Diluted EPS (Cont. Ops) | $0.45 | -$0.01 | -$1.48 | $0.74 | $3.16 | |
Weighted Average Basic Share | $26.9M | $27.1M | $31M | $32.1M | $32.3M | |
Weighted Average Diluted Share | $27.1M | $27.1M | $31M | $32.3M | $33.3M | |
EBITDA | $37.1M | $21.2M | -$24.3M | $59.8M | $152.3M | |
EBIT | $22.7M | $7.7M | -$38.4M | $43.8M | $137.5M | |
Revenue (Reported) | $879.2M | $684M | $800.6M | $1.1B | $1.3B | |
Operating Income (Reported) | $22M | $6.5M | -$40.7M | $51.7M | $139.3M | |
Operating Income (Adjusted) | $22.7M | $7.7M | -$38.4M | $43.8M | $137.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $164.7M | $207.7M | $299.8M | $345.9M | $358.9M | |
Revenue Growth (YoY) | -35.52% | 26.09% | 44.38% | 15.38% | 3.74% | |
Cost of Revenues | $146.2M | $204.5M | $264.2M | $282.3M | $288M | |
Gross Profit | $18.5M | $3.2M | $35.6M | $63.6M | $70.9M | |
Gross Profit Margin | 11.23% | 1.52% | 11.89% | 18.4% | 19.75% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $17.4M | $19.9M | $23.2M | $27.6M | $37.1M | |
Other Inc / (Exp) | $422K | $744K | -$342K | -$2M | $444K | |
Operating Expenses | $17.4M | $19.9M | $23.2M | $27.6M | $37.1M | |
Operating Income | $1.1M | -$16.7M | $12.4M | $36.1M | $33.7M | |
Net Interest Expenses | $2.3M | $2.5M | $5.2M | $1.8M | $555K | |
EBT. Incl. Unusual Items | -$780K | -$18.4M | $6.9M | $32.3M | $33.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$483K | -$7.4M | $1.4M | $8.3M | $9.1M | |
Net Income to Company | -$619K | -$12.1M | $7.1M | $26M | $26M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$619K | -$12.1M | $7.1M | $26M | $26M | |
Basic EPS (Cont. Ops) | -$0.02 | -$0.38 | $0.22 | $0.81 | $0.82 | |
Diluted EPS (Cont. Ops) | -$0.02 | -$0.38 | $0.22 | $0.79 | $0.79 | |
Weighted Average Basic Share | $27.1M | $32M | $32M | $32.2M | $31.9M | |
Weighted Average Diluted Share | $27.1M | $32M | $32.3M | $33.1M | $32.9M | |
EBITDA | $4.9M | -$12.6M | $15.8M | $38.8M | $39.3M | |
EBIT | $1.6M | -$16M | $12.1M | $35.2M | $35.4M | |
Revenue (Reported) | $164.7M | $207.7M | $299.8M | $345.9M | $358.9M | |
Operating Income (Reported) | $1.1M | -$16.7M | $12.4M | $36.1M | $33.7M | |
Operating Income (Adjusted) | $1.6M | -$16M | $12.1M | $35.2M | $35.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $765.7M | $725.7M | $999.3M | $1.3B | $1.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $682M | $667.2M | $939M | $1B | $1.1B | |
Gross Profit | $83.7M | $58.5M | $60.3M | $222.9M | $260.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $65.9M | $71.7M | $79.2M | $100.3M | $128.1M | |
Other Inc / (Exp) | $831K | $1.6M | $281K | -$12.5M | $2.2M | |
Operating Expenses | $65.9M | $71.7M | $79.2M | $100.3M | $128.1M | |
Operating Income | $17.8M | -$13.1M | -$18.9M | $122.6M | $132.1M | |
Net Interest Expenses | $8.9M | $11M | $18.5M | $11.9M | $3M | |
EBT. Incl. Unusual Items | $9.7M | -$22.5M | -$37.1M | $98.2M | $131.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.7M | -$9.4M | -$3.9M | $27.3M | $34.3M | |
Net Income to Company | $11M | -$14.3M | -$33.7M | $80.1M | $108.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $11M | -$14.3M | -$33.7M | $80.1M | $108.1M | |
Basic EPS (Cont. Ops) | $0.41 | -$0.46 | -$1.05 | $2.49 | $3.36 | |
Diluted EPS (Cont. Ops) | $0.41 | -$0.46 | -$1.05 | $2.47 | $3.23 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $32.8M | $1.8M | -$4.2M | $129.4M | $154.3M | |
EBIT | $18.6M | -$11.5M | -$18.6M | $113.3M | $139M | |
Revenue (Reported) | $765.7M | $725.7M | $999.3M | $1.3B | $1.4B | |
Operating Income (Reported) | $17.8M | -$13.1M | -$18.9M | $122.6M | $132.1M | |
Operating Income (Adjusted) | $18.6M | -$11.5M | -$18.6M | $113.3M | $139M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $295.1M | $336.9M | $535.5M | $663.6M | $672.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $262.2M | $317.5M | $492.4M | $536.4M | $541.6M | |
Gross Profit | $33M | $19.4M | $43.1M | $127.2M | $131.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $32.1M | $38.1M | $40M | $53.2M | $64.4M | |
Other Inc / (Exp) | $467K | $919K | -$1.1M | -$4.7M | $3.4M | |
Operating Expenses | $32.1M | $38.1M | $40M | $53.2M | $64.4M | |
Operating Income | $910K | -$18.7M | $3.1M | $74M | $66.8M | |
Net Interest Expenses | $4.3M | $5.6M | $9.4M | $4.3M | $902K | |
EBT. Incl. Unusual Items | -$2.9M | -$23.4M | -$7.4M | $65M | $69.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1M | -$9.2M | -$1.6M | $16.7M | $17.8M | |
Net Income to Company | -$2.2M | -$16.2M | -$4.2M | $52.2M | $54.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$2.2M | -$16.2M | -$4.2M | $52.2M | $54.8M | |
Basic EPS (Cont. Ops) | -$0.08 | -$0.53 | -$0.13 | $1.62 | $1.71 | |
Diluted EPS (Cont. Ops) | -$0.08 | -$0.53 | -$0.13 | $1.60 | $1.65 | |
Weighted Average Basic Share | $54.2M | $60.1M | $64.1M | $64.4M | $64.1M | |
Weighted Average Diluted Share | $54.2M | $60.1M | $64.3M | $65.5M | $66.2M | |
EBITDA | $8.2M | -$11.1M | $9M | $78.7M | $80.6M | |
EBIT | $1.4M | -$17.8M | $2M | $71.4M | $72.9M | |
Revenue (Reported) | $295.1M | $336.9M | $535.5M | $663.6M | $672.7M | |
Operating Income (Reported) | $910K | -$18.7M | $3.1M | $74M | $66.8M | |
Operating Income (Adjusted) | $1.4M | -$17.8M | $2M | $71.4M | $72.9M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $44.5M | $11.7M | $10.5M | $79M | $127.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $7.6M | $10M | $12.5M | $12.6M | $59.1M | |
Inventory | $56.5M | $125.2M | $143M | $135.3M | $127.8M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $8.2M | $9.2M | $8.5M | $9.2M | $8.8M | |
Total Current Assets | $116.9M | $156.1M | $174.5M | $236.1M | $323.4M | |
Property Plant And Equipment | $110.4M | $111M | $102.3M | $96.1M | $97.7M | |
Long-Term Investments | $14.3M | $14.8M | $10.7M | $17.6M | $32.1M | |
Goodwill | $18.8M | $18.8M | $18.8M | $18.8M | $18.8M | |
Other Intangibles | $51.6M | $49.4M | $47.4M | $45.4M | $43.6M | |
Other Long-Term Assets | $1M | $1.5M | $1.5M | $1.5M | $2.3M | |
Total Assets | $317.4M | $356M | $366.1M | $417.8M | $524.9M | |
Accounts Payable | $57.6M | $72.3M | $107.9M | $137.1M | $143.2M | |
Accrued Expenses | $15.8M | $12.3M | $16.4M | $32.9M | $55.8M | |
Current Portion Of Long-Term Debt | $9.9M | $14.9M | $19.8M | $19.8M | $5M | |
Current Portion Of Capital Lease Obligations | $1.3M | $1.3M | $566K | $583K | $975K | |
Other Current Liabilities | $18.6M | $16.2M | $12.9M | $31.1M | $21.6M | |
Total Current Liabilities | $111.6M | $124.8M | $164.8M | $229.6M | $236M | |
Long-Term Debt | $164.2M | $194.6M | $150.4M | $110.5M | $90M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $370.6M | $388.7M | $364.7M | $377.8M | $365.3M | |
Common Stock | $3K | $3K | $3K | $3K | $3K | |
Other Common Equity Adj | -$58.4M | -$44.8M | -$41.9M | -$31.9M | -$26.4M | |
Common Equity | -$53.2M | -$32.7M | $1.4M | $40M | $159.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$53.2M | -$32.7M | $1.4M | $40M | $159.6M | |
Total Liabilities and Equity | $317.4M | $356M | $366.1M | $417.8M | $524.9M | |
Cash and Short Terms | $44.5M | $11.7M | $10.5M | $79M | $127.7M | |
Total Debt | $174.1M | $209.4M | $170.2M | $130.3M | $95M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $18.7M | $14.9M | $17.8M | $93.1M | $130.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $6.5M | $11.2M | $13.6M | $11.4M | $15.8M | |
Inventory | $92M | $155.7M | $129.2M | $145.4M | $163.8M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $7.1M | $12.9M | $11.5M | $19.5M | $18.1M | |
Total Current Assets | $124.3M | $194.6M | $172M | $269.4M | $328.4M | |
Property Plant And Equipment | $111.8M | $107.7M | $99.9M | $95.2M | $104.1M | |
Long-Term Investments | $14M | $12.8M | $12.3M | $25.9M | $36M | |
Goodwill | $18.8M | $18.8M | $18.8M | $18.8M | $18.8M | |
Other Intangibles | $50.4M | $48.4M | $46.4M | $44.5M | $42.6M | |
Other Long-Term Assets | $1.8M | $1.9M | $2.3M | $2.6M | $2.1M | |
Total Assets | $326M | $397.9M | $364.3M | $456.5M | $543.7M | |
Accounts Payable | $80.8M | $111.9M | $136.6M | $138.8M | $153.7M | |
Accrued Expenses | $15.8M | $19.6M | $21.7M | $37.5M | $42.5M | |
Current Portion Of Long-Term Debt | $12.4M | $17.3M | $19.8M | $5M | $5M | |
Current Portion Of Capital Lease Obligations | $1.3M | $1.4M | $576K | $898K | $377K | |
Other Current Liabilities | $17.5M | $11.5M | $12.2M | $28.8M | $14.8M | |
Total Current Liabilities | $135.8M | $168.9M | $198.4M | $219.8M | $226.6M | |
Long-Term Debt | $156.4M | $139.6M | $119.8M | $92.3M | $87.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $378.6M | $370.3M | $365.5M | $350.7M | $353.3M | |
Common Stock | $3K | $3K | $3K | $3K | $3K | |
Other Common Equity Adj | -$57.7M | -$44.4M | -$41.5M | -$31.6M | -$26.3M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$52.6M | $27.6M | -$1.1M | $105.8M | $190.4M | |
Total Liabilities and Equity | $326M | $397.9M | $364.3M | $456.5M | $543.7M | |
Cash and Short Terms | $18.7M | $14.9M | $17.8M | $93.1M | $130.7M | |
Total Debt | $168.8M | $156.9M | $139.6M | $97.3M | $92.7M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $12.2M | -$289K | -$45.8M | $23.8M | $105.5M | |
Depreciation & Amoritzation | $14.4M | $13.4M | $14.1M | $16M | $14.8M | |
Stock-Based Compensation | $4.1M | $5.9M | $3.7M | $4.2M | $8.6M | |
Change in Accounts Receivable | $2.9M | -$2.3M | -$2.6M | -$40K | -$46.5M | |
Change in Inventories | $22.3M | -$68.7M | -$26.5M | $7.7M | $7.5M | |
Cash From Operations | $3.5M | -$54.2M | -$24.4M | $119.9M | $111.1M | |
Capital Expenditures | $19M | $12.2M | $6.5M | $8.5M | $15.3M | |
Cash Acquisitions | -- | -- | -- | -- | -$552K | |
Cash From Investing | -$18.8M | -$11.3M | -$6.5M | -$8.5M | -$15.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $199M | $117M | $135M | $45M | $136.2M | |
Long-Term Debt Repaid | -$209.8M | -$83.2M | -$176M | -$85.4M | -$172.4M | |
Repurchase of Common Stock | -- | -$517K | -$1.7M | -$376K | -$11.1M | |
Other Financing Activities | -$935K | -$2.5M | -$3M | -$3.3M | -$3.1M | |
Cash From Financing | -$11.1M | $32.8M | $29.7M | -$42.9M | -$46.6M | |
Beginning Cash (CF) | $71M | $44.5M | $11.7M | $10.5M | $79M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$26.5M | -$32.8M | -$1.2M | $68.5M | $48.7M | |
Ending Cash (CF) | $44.5M | $11.7M | $10.5M | $79M | $127.7M | |
Levered Free Cash Flow | -$15.5M | -$66.5M | -$30.9M | $111.4M | $95.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$619K | -$12.1M | $7.1M | $26M | $26M | |
Depreciation & Amoritzation | $3.3M | $3.4M | $3.7M | $3.6M | $3.9M | |
Stock-Based Compensation | $871K | $813K | $699K | $2.5M | $7.4M | |
Change in Accounts Receivable | -$1.6M | -$5.1M | -$4.5M | -$318K | -$1.8M | |
Change in Inventories | -$22.8M | -$13.7M | -$41K | -$2.9M | -$712K | |
Cash From Operations | $299K | $21.7M | $24.8M | $54.6M | $27.8M | |
Capital Expenditures | $3.7M | $1.9M | $2.6M | $2.7M | $9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$3.7M | -$1.9M | -$2.6M | -$2.7M | -$9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $20M | $30M | -- | -- | |
Long-Term Debt Repaid | -$2.9M | -$29M | -$40.1M | -$37.6M | -$1.3M | |
Repurchase of Common Stock | -- | -$19K | -$57K | -- | -$23M | |
Other Financing Activities | -- | -$202K | -$61K | -- | -- | |
Cash From Financing | -$1.8M | -$9M | -$10.1M | -$36M | -$24.1M | |
Beginning Cash (CF) | $23.9M | $4.1M | $5.9M | $77.3M | $136.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$5.2M | $10.8M | $12.1M | $15.8M | -$5.4M | |
Ending Cash (CF) | $18.7M | $14.9M | $18M | $93.1M | $130.7M | |
Levered Free Cash Flow | -$3.4M | $19.8M | $22.2M | $51.8M | $18.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $11M | -$14.3M | -$33.7M | $80.1M | $108.1M | |
Depreciation & Amoritzation | $14.1M | $13.3M | $14.4M | $16.2M | $15.3M | |
Stock-Based Compensation | $3.4M | $6.8M | $2.5M | $7.4M | $14M | |
Change in Accounts Receivable | $580K | -$4.7M | -$2.4M | $2.2M | -$4.4M | |
Change in Inventories | $52M | -$63.7M | $17.8M | -$16.2M | -$18.4M | |
Cash From Operations | $40.5M | -$54.5M | $31.7M | $130M | $110.5M | |
Capital Expenditures | $11.7M | $8.7M | $6.7M | $10.4M | $23.2M | |
Cash Acquisitions | -- | -- | -- | -- | -$1.1M | |
Cash From Investing | -$11.7M | -$7.8M | -$6.7M | -$10.4M | -$24.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $172M | $115M | $146.2M | -- | |
Long-Term Debt Repaid | -$210.1M | -$185.6M | -$133.1M | -$189.8M | -$5.9M | |
Repurchase of Common Stock | -- | -- | -- | -$620K | -$45.3M | |
Other Financing Activities | -$98K | -$2.7M | -$3.6M | -$3.1M | -- | |
Cash From Financing | -$44.1M | $58.4M | -$21.8M | -$44.5M | -$48.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$15.4M | -$3.9M | $3.1M | $75.1M | $37.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $28.7M | -$63.1M | $25M | $119.6M | $87.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.2M | -$16.2M | -$4.2M | $52.2M | $54.8M | |
Depreciation & Amoritzation | $6.8M | $6.7M | $7.1M | $7.3M | $7.7M | |
Stock-Based Compensation | $1.6M | $2.5M | $1.3M | $4.5M | $9.9M | |
Change in Accounts Receivable | $1.1M | -$1.2M | -$1.1M | $1.1M | $43.3M | |
Change in Inventories | -$35.4M | -$30.5M | $13.8M | -$10.1M | -$36M | |
Cash From Operations | -$11.2M | -$11.4M | $44.7M | $54.8M | $54.2M | |
Capital Expenditures | $7M | $3.5M | $3.7M | $5.6M | $13.6M | |
Cash Acquisitions | -- | -- | -- | -- | -$500K | |
Cash From Investing | -$7M | -$3.5M | -$3.7M | -$5.6M | -$14.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $55M | $35M | $136.2M | -- | |
Long-Term Debt Repaid | -$5.7M | -$108.1M | -$65.2M | -$169.6M | -$3.1M | |
Repurchase of Common Stock | -- | -$1.5M | -$57K | -$301K | -$34.5M | |
Other Financing Activities | -$2.5M | -$2.7M | -$3.3M | -$3.1M | -- | |
Cash From Financing | -$7.6M | $18M | -$33.4M | -$35M | -$37M | |
Beginning Cash (CF) | $68.4M | $15.8M | $16.4M | $156.3M | $263.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$25.8M | $3.2M | $7.5M | $14.1M | $3.1M | |
Ending Cash (CF) | $42.6M | $18.9M | $23.9M | $170.4M | $266.9M | |
Levered Free Cash Flow | -$18.2M | -$14.9M | $41M | $49.1M | $40.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.